Related Experiment Video
Updated: May 6, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
A Set of Multiresistant Isolates of Mycoplasma bovis Subtype ST-1 with a Variable Susceptibility to Quinolones Are
Juan Carlos Corrales1, Antonio Sánchez1, Xóchitl Hernández1
1Ruminant Health Research Group, Department of Animal Health, Faculty of Veterinary Sciences, University of Murcia, 30100 Murcia, Spain.
Abstract:
Mycoplasma bovis (M. bovis) is one of the worldwide most important infectious agents involved in respiratory complex diseases (RCD). In Spain, the endemic presence of subtypes ST-2 and ST-3 with phenotypic differences linked to their susceptibility to fluoroquinolones opened the way to develop control strategies focused on previous diagnosis of the subtype and the use of directed therapies when M. bovis were involved in RCD. Surprisingly, microbiological studies conducted during 2023 evidenced for the first time the presence of Spanish isolates of a new polC-subtype, previously classified as ST-1, recovered from calves with respiratory symptoms and pneumonia in different areas of the country (n = 16). Curiously, the minimum inhibitory concentration (MIC) to a panel of antimicrobials revealed phenotypic differences between these ST-1 isolates when using fluoroquinolones (FLQ). There is no geographical correlation between MIC profiles even for a set of 8 isolates recovered from different animals in the same flock. Sequencing of 4 genes (gyrA, gyrB, parC and parE) encoding quinolone resistance-determining regions (QRDR) evidenced the presence of accumulate mutations in 2 ST-1 isolates with high FLQ MICs, but not in all them (n = 3), thus suggesting that, as previously recorded for ST-2 isolates, other mechanisms should be involved in the acquisition of resistence to these antimicrobials. Additionally, as previously detected in the Spanish ST-2 and ST-3, subtype ST-1 isolates are also resistant to macrolides or lincosamides.
Insights
A new subtype of Mycoplasma bovis (ST-1) has been identified in Spain, exhibiting fluoroquinolone resistance. This discovery necessitates updated diagnostic and therapeutic strategies for bovine respiratory complex diseases.
Area of Science:
- Veterinary Microbiology
- Bovine Infectious Diseases
- Antimicrobial Resistance
Background:
- Mycoplasma bovis is a major cause of bovine respiratory complex diseases (RCD) globally.
- Spanish endemic subtypes ST-2 and ST-3 show varying fluoroquinolone susceptibility, guiding control strategies.
- Previous control strategies relied on subtype diagnosis for targeted therapy.
Purpose of the Study:
- To report the emergence of a novel Mycoplasma bovis ST-1 subtype in Spain.
- To investigate the antimicrobial susceptibility, particularly to fluoroquinolones, of this new ST-1 subtype.
- To explore potential resistance mechanisms in the identified ST-1 isolates.
Main Methods:
- Microbiological studies and isolation of Mycoplasma bovis from calves with respiratory symptoms.
- Determination of minimum inhibitory concentrations (MICs) for a panel of antimicrobials, including fluoroquinolones.
- Sequencing of quinolone resistance-determining region (QRDR) genes (gyrA, gyrB, parC, parE) in selected isolates.
Main Results:
- The first detection of Spanish Mycoplasma bovis ST-1 isolates from calves with pneumonia across different regions.
- Phenotypic variations in fluoroquinolone susceptibility were observed among ST-1 isolates, with no clear geographical correlation.
- While some ST-1 isolates showed QRDR mutations associated with high fluoroquinolone MICs, not all did, suggesting alternative resistance mechanisms.
- ST-1 isolates demonstrated resistance to macrolides and lincosamides, similar to Spanish ST-2 and ST-3 subtypes.
Conclusions:
- The emergence of Mycoplasma bovis ST-1 in Spain presents a new challenge for RCD control.
- Fluoroquinolone resistance in ST-1 isolates is complex, involving both QRDR mutations and potentially other uncharacterized mechanisms.
- The co-resistance to macrolides and lincosamides in ST-1 highlights the need for comprehensive antimicrobial stewardship in affected herds.
More Related Videos
Related Concept Videos
Development of Antibiotic Resistance
Bacterial Phylum Tenericutes
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial DNA Synthesis
Clinical Significance of Antibiotic Resistance

